title: Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
abstract: Both stress-system activation and melancholic depression are characterized by fear, constricted affect, stereotyped thinking, and similar changes in autonomic and neuroendocrine function. Because norepinephrine (NE) and corticotropin-releasing hormone (CRH) can produce these physiological and behavioral changes, we measured the cerebrospinal fluid (CSF) levels each hour for 30 consecutive hours in controls and in patients with melancholic depression. Plasma adrenocorticotropic hormone (ACTH) and cortisol levels were obtained every 30 min. Depressed patients had significantly higher CSF NE and plasma cortisol levels that were increased around the clock. Diurnal variations in CSF NE and plasma cortisol levels were virtually superimposable and positively correlated with each other in both patients and controls. Despite their hypercortisolism, depressed patients had normal levels of plasma ACTH and CSF CRH. However, plasma ACTH and CSF CRH levels in depressed patients were inappropriately high, considering the degree of their hypercortisolism. In contrast to the significant negative correlation between plasma cortisol and CSF CRH levels seen in controls, patients with depression showed no statistical relationship between these parameters. These data indicate that persistent stress-system dysfunction in melancholic depression is independent of the conscious stress of the disorder. These data also suggest mutually reinforcing bidirectional links between a central hypernoradrenergic state and the hyperfunctioning of specific central CRH pathways that each are driven and sustained by hypercortisolism. We postulate that alpha-noradrenergic blockade, CRH antagonists, and treatment with antiglucocorticoids may act at different loci, alone or in combination, in the treatment of major depression with melancholic features.
authors.affiliation: Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Wong
authors.forename: M A
authors.initials: MA
authors.lastname: Kling
authors.forename: P J
authors.initials: PJ
authors.lastname: Munson
authors.forename: S
authors.initials: S
authors.lastname: Listwak
authors.forename: J
authors.initials: J
authors.lastname: Licinio
authors.forename: P
authors.initials: P
authors.lastname: Prolo
authors.forename: B
authors.initials: B
authors.lastname: Karp
authors.forename: I E
authors.initials: IE
authors.lastname: McCutcheon
authors.forename: T D
authors.initials: TD
authors.lastname: Geracioti
authors.forename: M D
authors.initials: MD
authors.lastname: DeBellis
authors.forename: K C
authors.initials: KC
authors.lastname: Rice
authors.forename: D S
authors.initials: DS
authors.lastname: Goldstein
authors.forename: J D
authors.initials: JD
authors.lastname: Veldhuis
authors.forename: G P
authors.initials: GP
authors.lastname: Chrousos
authors.forename: E H
authors.initials: EH
authors.lastname: Oldfield
authors.forename: S M
authors.initials: SM
authors.lastname: McCann
authors.forename: P W
authors.initials: PW
authors.lastname: Gold
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D002940:Circadian Rhythm; D003346:Corticotropin-Releasing Hormone / Q000134:cerebrospinal fluid*; D003866:Depressive Disorder / Q000378:metabolism*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000134:cerebrospinal fluid*; D012890:Sleep; D013223:Statistics as Topic; D013312:Stress, Physiological
chemical_list: D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone; D009638:Norepinephrine